Timeline | Returns | Volume |
---|---|---|
Daily | 9.13% | 5,42,733 |
Weekly | 14.57% | 14,73,375 |
Monthly | 10.69% | 41,89,572 |
Timeline | Daily | Weekly | Monthly |
---|---|---|---|
APLLTD | 9.13% | 14.57% | 10.69% |
Index | - | - | - |
Peer Avg. | 1.19% | 4.12% | 11.38% |
Timeline | PE | PB | EV/EBIDTA | ROE | ROCE | Div. Yield |
---|---|---|---|---|---|---|
APLLTD | 27.39 | 2.77 | 17.07 | 10.23 | 11.44 | 1.80 |
Index | 35.44 | 5.98 | 16.81 | 16.99 | 18.41 | 1.19 |
Peer Avg. | 38.60 | 4.35 | 13.48 | 12.96 | 16.49 | 0.78 |
Metrics | Sales Growth | Profit Growth | ROE | ROCE |
---|---|---|---|---|
FY '21-22 | -1.12% | -52.09% | 10.23% | 11.44% |
FY '20-21 | 19.85% | 26.17% | 26.43% | 25.84% |
FY '19-20 | 14.98% | 46.86% | 29.48% | 25.19% |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
FY '21-22 | 5,170.59 | 4,279.13 | 942.28 | 529.60 |
FY '20-21 | 5,230.01 | 3,765.38 | 1,550.41 | 1,105.65 |
FY '19-20 | 4,369.16 | 3,166.28 | 1,282.80 | 885.02 |
Metrics | Sales | Expenditure | EBITDA | PAT |
---|---|---|---|---|
APLLTD | 5,170.59 | 4,279.13 | 942.28 | 529.60 |
NATCOPHARM | 1,856.30 | 1,618.05 | 335.05 | 154.55 |
GLENMARK | 10,223.24 | 8,218.98 | 2,394.91 | 1,495.72 |